CoChat
Sign Up
Cited by 286Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Increased Probability of GABA Release during Withdrawal from Morphine

Open access
Bonci, Antonello, Williams, John T.·1997·The Journal of Neuroscience
DOI 10.1523/jneurosci.17-02-00796.1997PMC PMC6573250
Open this paper in CoChat — free accountOpen PDF

Abstract

Opioid receptors located on interneurons in the ventral tegmental area (VTA) inhibit GABA A -mediated synaptic transmission to dopamine projection neurons. The resulting disinhibition of dopamine cells in the VTA is thought to play a pivotal role in drug abuse; however, little is known about how this GABA A synapse is affected after chronic morphine treatment. The regulation of GABA release during acute withdrawal from morphine was studied in slices from animals treated for 6–7 d with morphine. Slices containing the VTA were prepared and maintained in morphine-free solutions, and GABA A IPSCs were recorded from dopamine cells. The amplitude of evoked IPSCs and the frequency of spontaneous miniature IPSCs measured in slices from morphine-treated guinea pigs were greater than placebo-treated controls. In addition, activation of adenylyl cyclase, with forskolin, and cAMP-dependent protein kinase, with Sp-cAMPS, caused a larger increase in IPSCs in slices from morphine-treated animals. Conversely, the kinase inhibitors staurosporine and Rp-CPT-cAMPS decreased GABA IPSCs to a greater extent after drug treatment. The results indicate that the probability of GABA release was increased during withdrawal from chronic morphine treatment and that this effect resulted from an upregulation of the cAMP-dependent cascade. Increased transmitter release from opioid-sensitive synapses during acute withdrawal may be one adaptive mechanism that results from prolonged morphine treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.17-02-00796.1997

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IPSCs from morphine-treated animals show paired-pulse depression, unlike those from controls, which show paired-pulse facilitation. A , Recording of GABAA-mediated IPSCs from a control slice using the paired-pulse protocol ( left trace ). Normorphine (1 m M) depressed the IPSC ( middle trace ), and that inhibition was reversed by the addition of naloxone to the normorphine-containing solution ( right trace ). B , Examples from three different cells in slices from both placebo- and morphine-treated animals. C , Cumulative results showing the distribution of paired-pulse ratio for many cells in slices from placebo ( n 5 41)- and morphine ( n 5 41)-withdrawn slices. D , The paired-pulse ratio is independent of the stimulus strength. These results are the average from four cells in each group of animals.
Figure 1 IPSCs from morphine-treated animals show paired-pulse depression, unlike those from controls, which show paired-pulse facilitation. A , Recording of GABAA-mediated IPSCs from a control slice using the paired-pulse protocol ( left trace ). Normorphine (1 m M) depressed the IPSC ( middle trace ), and that inhibition was reversed by the addition of naloxone to the normorphine-containing solution ( right trace ). B , Examples from three different cells in slices from both placebo- and morphine-treated animals. C , Cumulative results showing the distribution of paired-pulse ratio for many cells in slices from placebo ( n 5 41)- and morphine ( n 5 41)-withdrawn slices. D , The paired-pulse ratio is independent of the stimulus strength. These results are the average from four cells in each group of animals.CC-BY-NC-SA · From the PDF
Figure 2 Forskolin augments the IPSC. This augmentation is significantly larger in morphine-withdrawn slices than in the placebo controls ( p , 0.05). A , Examples of experiments from placebo- and morphinetreated animals. B , The amplitude of the first IPSC is plotted as a function of time in cells from placebo ( open circles )- and morphine ( solid circles )-withdrawn slices. Results are from four slices for each group. Forskolin (10 m M) increased the amplitude of the IPSC to a greater extent and for a more prolonged period in morphine-withdrawn slices than in controls. C , The concentration response to forskolin. The amplitude of the first IPSC in the paired-pulse protocol is plotted as a function of the concentration of forskolin. The amplitude was normalized against the mean of the first 10 IPSCs for each cell. Results were obtained from four cells from four different animals in each group. The data were fit with a least-squares regression from a logistic equation and gave estimates of the EC 50 and maximum effect of forskolin of 1.8 m M and 66% increase in control and 1.5 m M and 125% increase in morphine-withdrawn slices.
Figure 2 Forskolin augments the IPSC. This augmentation is significantly larger in morphine-withdrawn slices than in the placebo controls ( p , 0.05). A , Examples of experiments from placebo- and morphinetreated animals. B , The amplitude of the first IPSC is plotted as a function of time in cells from placebo ( open circles )- and morphine ( solid circles )-withdrawn slices. Results are from four slices for each group. Forskolin (10 m M) increased the amplitude of the IPSC to a greater extent and for a more prolonged period in morphine-withdrawn slices than in controls. C , The concentration response to forskolin. The amplitude of the first IPSC in the paired-pulse protocol is plotted as a function of the concentration of forskolin. The amplitude was normalized against the mean of the first 10 IPSCs for each cell. Results were obtained from four cells from four different animals in each group. The data were fit with a least-squares regression from a logistic equation and gave estimates of the EC 50 and maximum effect of forskolin of 1.8 m M and 66% increase in control and 1.5 m M and 125% increase in morphine-withdrawn slices.CC-BY-NC-SA · From the PDF
Figure 4 The cAMP analog Sp-cAMPS is more effective in increasing the IPSC in slices from morphine-withdrawn slices than placebo controls. The amplitude of the electrically evoked IPSC is plotted as a function of time. A , Top , Example of one experiment in a slice taken from a control animal. The cAMP analog Sp-cAMPS (100 m M) has no effect on the amplitude of the IPSC, whereas a low concentration of forskolin (1 m M) increased the amplitude of the IPSC. Bottom , Average of four such experiments in slices taken from four different animals. The average amplitude of IPSCs over the first 5 min was used to normalize the data. B , Top , An experiment in a single cell taken from a morphine-treated animal. In this case, cAMP analog Sp-cAMPS caused an increase in the IPSC that was about the same as that induced by forskolin. Bottom , Normalized and averaged results from four experiments.
Figure 4 The cAMP analog Sp-cAMPS is more effective in increasing the IPSC in slices from morphine-withdrawn slices than placebo controls. The amplitude of the electrically evoked IPSC is plotted as a function of time. A , Top , Example of one experiment in a slice taken from a control animal. The cAMP analog Sp-cAMPS (100 m M) has no effect on the amplitude of the IPSC, whereas a low concentration of forskolin (1 m M) increased the amplitude of the IPSC. Bottom , Average of four such experiments in slices taken from four different animals. The average amplitude of IPSCs over the first 5 min was used to normalize the data. B , Top , An experiment in a single cell taken from a morphine-treated animal. In this case, cAMP analog Sp-cAMPS caused an increase in the IPSC that was about the same as that induced by forskolin. Bottom , Normalized and averaged results from four experiments.CC-BY-NC-SA · From the PDF
Figure 5 The protein kinase inhibitors staurosporine ( A , 300 nM) and Rp-CPT-cAMPS ( B , 100 m M) decreased the IPSC in slices from both placeboand morphine-treated animals. The inhibition is greater in morphine-withdrawn slices. In all plots, the IPSC amplitudes were normalized to the average determined over the first 5 min of the experiment. Plots on the left are from control animals ( Placebo ), and plots on the right are from morphine-treated animals ( Withdrawn ). A , A low concentration of forskolin (1 m M) increased the amplitude of the IPSC, and staurosporine decreased the amplitude of the IPSC and blocked the forskolin-induced augmentation ( n 5 4). The plot labeled Withdrawn is the same experiment as shown at the left in slices taken from four morphine-treated animals. The inhibition induced by staurosporine is significantly larger than in controls ( p , 0.05). B , The cAMP analog Rp-CPT-cAMPS, a cAMP-dependent kinase inhibitor, produced a greater inhibition of the amplitude of IPSCs in slices from both withdrawn slices than placebo controls ( n 5 4 for each group; p , 0.05). The same protocol was used as described for A .
Figure 5 The protein kinase inhibitors staurosporine ( A , 300 nM) and Rp-CPT-cAMPS ( B , 100 m M) decreased the IPSC in slices from both placeboand morphine-treated animals. The inhibition is greater in morphine-withdrawn slices. In all plots, the IPSC amplitudes were normalized to the average determined over the first 5 min of the experiment. Plots on the left are from control animals ( Placebo ), and plots on the right are from morphine-treated animals ( Withdrawn ). A , A low concentration of forskolin (1 m M) increased the amplitude of the IPSC, and staurosporine decreased the amplitude of the IPSC and blocked the forskolin-induced augmentation ( n 5 4). The plot labeled Withdrawn is the same experiment as shown at the left in slices taken from four morphine-treated animals. The inhibition induced by staurosporine is significantly larger than in controls ( p , 0.05). B , The cAMP analog Rp-CPT-cAMPS, a cAMP-dependent kinase inhibitor, produced a greater inhibition of the amplitude of IPSCs in slices from both withdrawn slices than placebo controls ( n 5 4 for each group; p , 0.05). The same protocol was used as described for A .CC-BY-NC-SA · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

Sorted by citations

See all 286

Related

Metadata

Authors
Bonci, A., & Williams, J. T.
Affiliations
Oregon Health & Science University (US)
ORCID
Venue
The Journal of Neuroscience
Publisher
Society for Neuroscience
Published
1997-01-15
Volume
17
Issue
2
Pages
796-803
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
DOI
10.1523/jneurosci.17-02-00796.1997
PMC
PMC6573250
OpenAlex
W2169322025
Cited by
286
References
45
Citations by year
2026: 4 · 2025: 8 · 2024: 3 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 10 · 2015: 8 · 2014: 15 · 2013: 5 · 2012: 12
FWCI
2.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Drug Abuse (R01DA008163, DA-08163)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
morphine withdrawal, GABA release, ventral tegmental area, dopaminergic neurons, miniature IPSCs, opioid receptors, cAMP signaling, adenylate cyclase, protein kinase A, chronic morphine administration, synaptic plasticity, drug addiction
MeSH terms
Adenylyl Cyclase Inhibitors, Action Potentials, Cyclic AMP, Adenylyl Cyclases, Animals, Dopamine, Enzyme Activation, Enzyme Inhibitors, Colforsin, gamma-Aminobutyric Acid, Guinea Pigs, Interneurons, Morphine, Nerve Tissue Proteins, Organophosphorus Compounds, Picrotoxin, Receptors, GABA-A, Salicylamides, Serotonin, Strychnine, Substance Withdrawal Syndrome, Tegmentum Mesencephali, Thionucleotides, Phorbol 12,13-Dibutyrate, Signal Transduction, 2-Amino-5-phosphonovalerate, Cyclic AMP-Dependent Protein Kinases, Patch-Clamp Techniques, Dopamine Antagonists, Excitatory Amino Acid Antagonists, 6-Cyano-7-nitroquinoxaline-2,3-dione, GABA Antagonists, Staurosporine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review